ScoreWhy is Cisen Pharmaceutical Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -1.10% and Operating profit at 0.34% over the last 5 years
2
The company has declared Negative results for the last 3 consecutive quarters
- NET SALES(9M) At CNY 2,583.78 MM has Grown at -12.88%
- INVENTORY TURNOVER RATIO(HY) Lowest at 2.15 times
- OPERATING PROFIT(Q) Lowest at CNY 85.93 MM
3
With ROE of 7.41%, it has a very attractive valuation with a 1.48 Price to Book Value
- Over the past year, while the stock has generated a return of 23.82%, its profits have fallen by -18.8%
- At the current price, the company has a high dividend yield of 2.2
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Cisen Pharmaceutical Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Cisen Pharmaceutical Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Cisen Pharmaceutical Ltd.
-4.2%
0.14
50.30%
China Shanghai Composite
21.43%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-1.89%
EBIT Growth (5y)
-5.50%
EBIT to Interest (avg)
61.55
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.62
Tax Ratio
9.90%
Dividend Payout Ratio
37.40%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.05%
ROE (avg)
7.85%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
0.94
EV to EBIT
11.51
EV to EBITDA
7.18
EV to Capital Employed
0.89
EV to Sales
0.88
PEG Ratio
NA
Dividend Yield
4.30%
ROCE (Latest)
7.72%
ROE (Latest)
6.32%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 754.09 MM
RAW MATERIAL COST(Y)
Fallen by -2.02% (YoY
CASH AND EQV(HY)
Highest at CNY 6,606.56 MM
-10What is not working for the Company
NET PROFIT(HY)
At CNY 173.32 MM has Grown at -33.64%
NET SALES(HY)
At CNY 1,711.29 MM has Grown at -9.91%
ROCE(HY)
Lowest at 6.58%
Here's what is working for Cisen Pharmaceutical Ltd.
Operating Cash Flow
Highest at CNY 754.09 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Cash and Eqv
Highest at CNY 6,606.56 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -2.02% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Cisen Pharmaceutical Ltd.
Net Profit
At CNY 173.32 MM has Grown at -33.64%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Net Sales
At CNY 1,711.29 MM has Grown at -9.91%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
